Rapid discrimination between BRO β-lactamases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis
- 31 January 2001
- journal article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 39 (1), 65-67
- https://doi.org/10.1016/s0732-8893(00)00220-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Genesis of BRO β‐lactamase‐producing Moraxella catarrhalis: evidence for transformation‐mediated horizontal transferMolecular Microbiology, 2000
- The β‐lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish childrenAPMIS, 1996
- Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USAJournal of Antimicrobial Chemotherapy, 1996
- β-Lactamases de Branhamella catarrhalis et leurs implications phénotypiquesResearch in Microbiology, 1995
- Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase patternJournal of Antimicrobial Chemotherapy, 1994
- Branhamella catarrhalis: an organism gaining respect as a pathogenClinical Microbiology Reviews, 1990
- BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunataAntimicrobial Agents and Chemotherapy, 1989
- beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acidAntimicrobial Agents and Chemotherapy, 1982
- PATHOGENICITY OF AND β-LACTAMASE PRODUCTION BY BRANHAMELLA (NEISSERIA) CATARRHALISThe Lancet, 1977
- In vitro sensitivity to penicillin V and β-lacta-mase production of Branhamella catarrhalisJournal of Antimicrobial Chemotherapy, 1977